Canada markets closed

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0168+0.0026 (+17.96%)
At close: 03:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 769.49k
Enterprise Value 44.14M
Trailing P/E 0.34
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.90
Price/Book (mrq)N/A
Enterprise Value/Revenue 2.42
Enterprise Value/EBITDA -2.75

Trading Information

Stock Price History

Beta (5Y Monthly) -1.16
52-Week Change 3-99.28%
S&P500 52-Week Change 322.36%
52 Week High 33.7500
52 Week Low 30.0120
50-Day Moving Average 30.0196
200-Day Moving Average 30.1231

Share Statistics

Avg Vol (3 month) 3834.74k
Avg Vol (10 day) 3555.11k
Shares Outstanding 545.94M
Implied Shares Outstanding 645.94M
Float 845.94M
% Held by Insiders 10.00%
% Held by Institutions 10.22%
Shares Short (Jul 29, 2022) 469.46k
Short Ratio (Jul 29, 2022) 40.19
Short % of Float (Jul 29, 2022) 411.01%
Short % of Shares Outstanding (Jul 29, 2022) 410.98%
Shares Short (prior month Jun 30, 2022) 4142.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 18, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:125
Last Split Date 3May 18, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 290.81%
Operating Margin (ttm)-69.85%

Management Effectiveness

Return on Assets (ttm)-62.46%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)18.22M
Revenue Per Share (ttm)3.77
Quarterly Revenue Growth (yoy)2,573.50%
Gross Profit (ttm)N/A
EBITDA -17.37M
Net Income Avi to Common (ttm)49.99M
Diluted EPS (ttm)0.0500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)43.37M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.13
Book Value Per Share (mrq)-3.32

Cash Flow Statement

Operating Cash Flow (ttm)-8.97M
Levered Free Cash Flow (ttm)-7.15M